These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 8692595)

  • 21. Evaluation of the efficacy of natural human interferon alpha lozenges on the clinical course of childhood neoplasia and in chronic hepatitis B virus infection in patients who were successfully treated for pediatric malignancies.
    Balcerska A; Bohdan Z; Drozyńska E; Kozielska E; Szarszewski A; Georgiades JA
    Arch Immunol Ther Exp (Warsz); 1993; 41(3-4):221-7. PubMed ID: 8129565
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy of long-term interferon therapy in chronic hepatitis B patients with HBV genotype C.
    Sakai T; Shiraki K; Inoue H; Okano H; Deguchi M; Sugimoto K; Ohmori S; Murata K; Nakano T
    Int J Mol Med; 2002 Aug; 10(2):201-4. PubMed ID: 12119559
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chronic hepatitis B virus in children in Israel: clinical and epidemiological characteristics and response to interferon therapy.
    Neudorf-Grauss R; Bujanover Y; Dinari G; Broide E; Neveh Y; Zahavi I; Reif S
    Isr Med Assoc J; 2000 Feb; 2(2):164-8. PubMed ID: 10804945
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of chronic hepatitis B (HBeAg-HBV DNA-positive) with lymphoblastoid alpha interferon with or without corticosteroids: short- and long-term follow-up.
    Zavaglia C; Bottelli R; Bellati G; Asti L; Mondazzi L; Iamoni G; Zanetti A; Tanzi E; Fesce E; Gelosa F; Maggi G; Ideo G
    Ital J Gastroenterol; 1996; 28(6):324-31. PubMed ID: 8891847
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of the long-term effects of treatment with oral and parenteral interferon alpha in chronic viral hepatitis patients.
    Zielińska W; Korczak-Rogoń A; Paszkiewicz J; Kowalik M; Cummins JM; Georgiades JA
    Arch Immunol Ther Exp (Warsz); 1996; 44(5-6):359-66. PubMed ID: 9017152
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predictive factors and virological response to interferon treatment in children with chronic hepatitis B.
    Söderström A; Lindh M; Ekholm K; Conradi N; Horal P; Krantz M; Hultgren C; Norkrans G
    Scand J Infect Dis; 2005; 37(1):40-7. PubMed ID: 15764189
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of alpha-interferon therapy of chronic hepatitis patients infected with wild type hepatitis B virus and HBEAG-minus mutant.
    Husa P; Chalupa P; Stroblová H; Husová L; Slesinger P
    Acta Virol; 2001; 45(5-6):293-7. PubMed ID: 12083328
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effectiveness of lamivudine and interferon-alpha combination therapy versus interferon-alpha monotherapy for the treatment of HBeAg-negative chronic hepatitis B patients: a randomized clinical trial.
    Karabay O; Tamer A; Tahtaci M; Vardi S; Celebi H
    J Microbiol Immunol Infect; 2005 Aug; 38(4):262-6. PubMed ID: 16118673
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Alpha-interferon in the treatment of chronic hepatitis C in children].
    Cinquetti M; Marchi D
    Pediatr Med Chir; 1995; 17(6):501-7. PubMed ID: 8668583
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of viral replication in children with chronic hepatitis B with and without interferon treatment.
    Lazăr C; Grigorescu-Sido P; Manasia R; Mireştean S; Skorka C; Neculoiu D; Molnar G; Cocean S
    Rom J Gastroenterol; 2005 Sep; 14(3):219-24. PubMed ID: 16200230
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Interferon therapy in cildren with chronic hepatitis and chronic renal failure treated with dialysis].
    Szczepańska M; Szprynger K; Morawiec-Knysak A; Schneiberg B; Augustyn-Iwachów T; Dyduch A
    Pol Merkur Lekarski; 2000 Sep; 9 Suppl 1():33-6. PubMed ID: 11081342
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Liver histology of children with chronic hepatitis treated with interferon-alpha alone or in combination with lamivudine.
    Kuloglu Z; Krsaçloglu CT; Kansu A; Erden E; Girgin N
    J Pediatr Gastroenterol Nutr; 2007 Nov; 45(5):564-8. PubMed ID: 18030234
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Therapy for chronic viral hepatitis.
    Alvarez F
    Clin Invest Med; 1996 Oct; 19(5):381-8. PubMed ID: 8889278
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Individualization of interferon therapy using serum hepatitis B virus DNA to reduce viral relapse in patients with chronic hepatitis B: a randomized controlled trial.
    Chung YH; Song BC; Lee GC; Shin JW; Ryu SH; Jung SA; Yoo K; Lee HC; Lee YS; Suh DJ
    Eur J Gastroenterol Hepatol; 2003 May; 15(5):489-93. PubMed ID: 12702905
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatitis B virus-specific T-cell proliferation and cytokine secretion in chronic hepatitis B e antibody-positive patients treated with ribavirin and interferon alpha.
    Rico MA; Quiroga JA; Subirá D; Castañón S; Esteban JM; Pardo M; Carreño V
    Hepatology; 2001 Jan; 33(1):295-300. PubMed ID: 11124848
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Management of chronic hepatitis B].
    Telegdy L
    Orv Hetil; 1997 Jun; 138(22 Suppl 1):1462-5. PubMed ID: 9221375
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Higher efficacy of sequential therapy with interferon-alpha and lamivudine combination compared to lamivudine monotherapy in HBeAg positive chronic hepatitis B patients.
    Sarin SK; Kumar M; Kumar R; Kazim SN; Guptan RC; Sakhuja P; Sharma BC
    Am J Gastroenterol; 2005 Nov; 100(11):2463-71. PubMed ID: 16279901
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term follow-up of alpha-interferon treatment of patients with chronic hepatitis B.
    van Zonneveld M; Honkoop P; Hansen BE; Niesters HG; Darwish Murad S; de Man RA; Schalm SW; Janssen HL
    Hepatology; 2004 Mar; 39(3):804-10. PubMed ID: 14999700
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Epidemiology of HBV infections and possibilities for therapeutic actions in children and adolescents with end-stage renal failure treated with dialysis].
    Zwolińska D; Inglot M; Makulska I; Gładysz A; Szprynger K; Szczepańska M; Pietrzyk J; Zachwieja K; Zurowska A; Zachwieja J; Rajkowski T; Jobs K; Latoszyńska J; Jander A
    Pol Merkur Lekarski; 2001 Apr; 10(58):267-70. PubMed ID: 11434173
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multicenter retrospective study of response to interferon in chronic hepatitis B.
    Martín-Vivaldi R; Nogueras F; Vignote ML; Salmerón J; Aguilar J; Romero M; Andrade R; De la Mata M; Moreno JM; Pérez J; García G; López de Hierro M; Gómez F; Palacios A; Otero S; Suárez E; Poyatos A; Quintero D
    Rev Esp Enferm Dig; 2000 Sep; 92(9):561-72. PubMed ID: 11138238
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.